![David Tweardy](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Tweardy
No open positions remaining
Net worth: 2 M $ as of 2026-05-30
Health Technology
Profile
David J.
Tweardy is associated with Tvardi Therapeutics, Inc. as the founder.
He held the position of President & Director at the company which was founded in 2017.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
6.92% | 2026-03-30 | 649,046 ( 6.92% ) | 2 M $ | 2026-05-30 |
Former positions of David Tweardy
| Companies | Position | End |
|---|---|---|
Tvardi Therapeutics, Inc.
 Tvardi Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops novel and oral molecule therapies for STAT3 to treat fibrosis-driven diseases | Founder | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 1 |
|---|---|
Tvardi Therapeutics, Inc.
Tvardi Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops novel and oral molecule therapies for STAT3 to treat fibrosis-driven diseases | Health Technology |
- Stock Market
- Insiders
- David Tweardy
